CBSTF (Cannabist Company Holdings) YoY EBITDA Growth : -460.00% (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cannabist Company Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -460.00%.

Cannabist Company Holdings's EBITDA per Share for the three months ended in Mar. 2025 was $-0.03.

Cannabist Company Holdings YoY EBITDA Growth Historical Data

The historical data trend for Cannabist Company Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings YoY EBITDA Growth Chart

Cannabist Company Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-4.19

60.17

111.70

386.36

-41.12

Cannabist Company Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															-200.00	250.00	1,880.00	-164.95	-460.00

Cannabist Company Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cannabist Company Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(0.063	-	0.107)	/	\| 0.107 \|
=	-41.12 %

Cannabist Company Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(-0.028	-	-0.005)	/	\| -0.005 \|
=	-460.00 %

Cannabist Company Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabist Company Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (OTCPK:CBSTF) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

VW5:Germany CBST:Canada

Address

321 Billerica Road, Suite 204, Chelmsford, MA, USA, 01824

Website

https://www.cannabistcompany.com

Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.

Executives

David Sirolly	officer: Chief Legal Officer/GC	C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Julie A Hill	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Jeff Clarke	director	COMPUTER ASSOCIATES INTERNATIONAL INC, ONE COMPUTER ASSOCIATES PLAZA, ISLANDA NY 11746
Derek Watson	officer: Chief Financial Officer	C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
David James Hart	officer: Chief Operating Officer	C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Alison Worthington	director	C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Bryan Olson	officer: Chief People/Admin Officer	C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Nicholas Vita	director, officer: Chief Executive Officer	C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Rosemary Mazanet	officer: Chief Scientific Officer	175 TOYOTA PLAZA, 7TH FLOOR, MEMPHIS TN 38103
Guy Hussussian	officer: Chief Data Officer	C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Jesse Channon	officer: Chief Growth Officer	C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Michael Abbott	director, officer: Chairman	C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Philip Goldberg	director	C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Frank Savage	director
Kennedy James A C	director	T ROWE PRICE GROUP INC, 100 E PRATT ST, BALTIMORE MD 21202